Preferred Name |
tazarotene |
|
Synonyms |
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester |
|
ID |
http://purl.bioontology.org/ontology/MESH/C086827 |
|
altLabel |
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester AGN 190168 AGN-190168 Tazorac ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate |
|
cui |
C0253908 C0723607 C0288792 |
|
HM |
D009539 |
|
II |
D005782 D011355 D012176 |
|
Inverse of RB |
81BDR9Y8PS |
|
isa |
http://purl.bioontology.org/ontology/MESH/D003879 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
19940517 |
|
MeSH Frequency |
422 |
|
MMR |
20141103 |
|
notation |
C086827 |
|
PA |
D003879 D013723 D007641 |
|
PI |
*RETINOIDS (94) |
|
prefLabel |
tazarotene |
|
RR |
118292-40-3 |
|
SC |
1 |
|
Scope Statement |
a topical acetylenic retinoid; a topical kerytolytic |
|
SRC |
J Am Acad Dermatol 1994 Apr;30(4):581-90 |
|
TERMUI |
T260117 T463632 T260118 T260116 T260115 |
|
TH |
NLM (2001) NLM (1994) USAN (1994) INN (19XX) FDA SRS (2015) |
|
tui |
T109 T121 |
Create mapping